Fig. 1From: Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapyStudy Flow chart (IS: Immunosuppressive group, HC: Healthy controls, INF: Infection group) * HC Group: 173 participants included in the study with database screening ** INF Group: 50 participants included in the study with database screeningBack to article page